Related Experiment Videos
Intravenous cidofovir for diffuse genital warts in the setting of multifactorial immunosuppression
R Blaizot1, A-S Dutkiewicz1, S Guillet1
1Dermatology Department, Oncodermatology Unit, CHU de Bordeaux, University of Bordeaux, Bordeaux, France.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cutaneous leishmaniasis: 2026 guidelines for diagnosis and treatment.
Annales de dermatologie et de venereologie·2026
Excision-cryosurgery of auricular keloids associated with active follow-up: A retrospective study of 61 patients.
Annales de dermatologie et de venereologie·2026
Prevalence of sleep disorders in patients with bullous pemphigoid.
Annales de dermatologie et de venereologie·2026
Value of tacrolimus 0.1% in the treatment of vitiligo in the era of targeted therapy.
Annales de dermatologie et de venereologie·2025
Radiation therapy on lentigo maligna: A single-centre retrospective study on 91 patients.
Annales de dermatologie et de venereologie·2025
Management of chronic urticaria: Current status and future prospect.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Systemic treatment of cutaneous leishmaniasis: A systematic review and meta-analysis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Five-year survival impact of adjuvant anti-PD-1 therapy in a nationwide cohort of stage III melanoma.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Dendritic Cells in the Immunoregulation of Myocardial Infarction: Mechanisms and Therapeutic Strategies.
Cardiovascular drugs and therapy·2026
Vascular Immunometabolism in Atherosclerosis: Emerging Roles of Glycometabolic Reprogramming in Immune and Vascular Cells.
Cardiovascular drugs and therapy·2026
Malignancies in patients with inborn errors of immunity: insights from 20-years of clinical experience in Qatar.
Frontiers in immunology·2026